Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

Vani Hari, a campaigner who has been pushing Kelloggs to remove the dye from its cereals, said: 'Red No. 3 being allowed in ...

Thus, there is a need for cancer drugs that kill tumor cells selectively and aggressively, while limiting side effects. To address this challenge, Paul Hergenrother and colleagues previously ...

THE size of a person’s waist may provide a clue to their likelihood of developing cancer, a new study reveals. It found both men and women carrying excess weight around the waistline increased ...

Patients with low-risk differentiated thyroid cancer show similar outcomes ... and having a larger tumor size. Biologic events were the most common, accounting for 74% of events, while biologic ...

a scientist revealed she had also reversed her stage three breast cancer using the same method — by combining a measles virus and flu-like pathogen and altering them to attack tumors.